A guide to applying the Good Publication Practice 3 Guidelines in the Asia-Pacific region

, , , , , , , ,
1 Kainic Medical Communications Limited, Dunedin, New Zealand
2 Proscribe Medical Affairs, Envision Pharma Group, Tokyo, Japan
3 MIMS (Hong Kong) Limited, Hong Kong, Hong Kong
4 AMICULUM (Singapore) Pte Limited, Singapore, Singapore
5 Cactus Communications Pvt Limited, Mumbai, India
6 AstraZeneca China, Shanghai, China
7 Syneos Health, Gordon, New South Wales, Australia
8 AstraZeneca Australia, Macquarie Park, New South Wales, Australia
DOI
10.7287/peerj.preprints.27892v2
Published
Accepted
Subject Areas
Clinical Trials, Drugs and Devices, Ethical Issues, Legal Issues, Science and Medical Education
Keywords
Asia-Pacific, Authorship, Conflict of interest, Disclosures, Ethics, Good Publication Practice, Manuscript development
Copyright
© 2019 Hesp et al.
Licence
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ Preprints) and either DOI or URL of the article must be cited.
Cite this article
Hesp B, Arai K, Chu M, Chuah S, Curameng JM, Kamat S, Ma Z, Sakko A, Fernandez H. 2019. A guide to applying the Good Publication Practice 3 Guidelines in the Asia-Pacific region. PeerJ Preprints 7:e27892v2

Abstract

Numerous recommendations and guidelines aim to improve the quality, timeliness and transparency of medical publications. However, these guidelines use ambiguous language that can be challenging to interpret, particularly for speakers of English as a second language. Cultural expectations within the Asia-Pacific region raise additional challenges. Several studies have suggested that awareness and application of ethical publication practices in the Asia-Pacific region is relatively low compared with other regions. However, guidance on applying ethical publication practice guidelines in the Asia-Pacific region is lacking. This review aims to improve publication practices in the Asia-Pacific region by providing guidance on applying the 10 principles of the Good Publication Practice 3 (GPP3) guidelines and the International Committee of Medical Journal Editors (ICMJE) criteria for authorship. Recommendations are provided for encore presentations, applying the ICMJE authorship criteria in the context of regional cultural expectations, and the role of study sponsors and professional medical writers. Ongoing barriers to compliance with guidelines are also highlighted, and additional guidance is provided to support authors submitting manuscripts for publication. The roles of regional journals, regulatory authorities and professional bodies in improving practices are also discussed.

Author Comment

All amendments made in response to the second round of peer review at Research Integrity and Peer Review have been incorporated into the manuscript. This version reflects the re-submitted version.